Geez bud there are over 10 products reaching consumer and Healthcare sectors worth Multi billins and patent protected ...you're DD needs a lot of work.
OUTPERFORM Rating with $17.41 Target by End of 2016 Named The Ruth Group as IR firm, Medical Device and Up List Specialists
Licensing Agreement for Use of RXSF's Patents by Talon Brands Lcc Plus Distribution
Expected Revenues by End of 2018 Approx. $150,000,000+ from a $85 BILLION COMBINED MARKET, that's 0.18% which 1-2% is easily attainable. $850m to $1.7B Annually.
Share Structure 500m A/S, 1.4m O/S & 300k Float
Up List to National Exchange.
Insiders Acquired 81% of Outstanding Shares PRIOR to split and PURCHASED $9000 in Commons Immediately after Split. Form 4's Issued.
FDA/510K for SafeDose & MyDose both Multi Billion $ Markets with World Wide Exclusivity and market Cornered with addition of new patents.
Major Pharmaceutical Partner coming due to FDA Prerequisite.
FUTURE CUSTOMERS: HOSPIRA $4.5B Annually (Owned by Pfzier), BAXTER INTERNATIONAL $15B Annually, CAREFUSION owned by Becton- Dickinson $10.2B Annually, SMITH MEDICAL$1B Annually.
In Store Sales at 7,800 CVS Health Stores, 4 National Televised Commercials with CVS.
Current Partners CVS Health, Cardinal Health, McKesson and soon Amerisource, all 4 on NYSE generating Billions.
Expect Government Announcements soon. Drug Prevention is at a peak.
2 Major Products Rx SafeDose & Rx MyDose
Plus numerous other to be Launched RX DrugSafe, RX DrugSafe Pro, RX DruSafe Mini, RX DrugSafe IC, Rx DrugSafe EMS , Rx DrugSafe MMS, RX DrufSafe Cool & Rx FieldLock, once again Multi Billion $ markets.
Expect MAJOR BANK FINANCING $10's of Millions...hearing $25-$35 Million. Yah thank me later.
$25 PPS is $34m Cap, Company expects $50m Cap relatively easy with sales announcements coming soon. (2016 will be a Big Year)